The gene that codes for FAS has been investigated as a possible oncogene.[35] FAS is upregulated in breast cancers and as well as being an indicator of poor prognosis may also be worthwhile as a chemotherapeutic target.[36][37] FAS inhibitors are therefore an active area of drug discovery research.[38][39][40]